Of these ten, six hub genes (CTSG, MMP9, PRTN3, RETN, RNASE2 and RNASE3) may be used as CML diagnostic markers. The gene discussed is PRTN3; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.